Amrutanjan Health Care Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

749.15

-2.95 (-0.39%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

749.15

-2.95 (-0.39%)
16:02 Dec 20

Quality

82/100
High Financial Strength

Valuation

27/100
Expensive Valuation

Technical

58/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017
Net Sales	137.65	141.73	166.57	186.74	223.98
Operating Expenses +	120.23	119.92	142.81	155.95	194.96
Raw Material	59.17	56.14	62.49	66.46	88.51
Increase Decrease in Cost	0.98	0.87	0.26	0.58	-1.93
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	21.03	22.82	25.87	28.55	33.58
Miscellaneous Expenses	45.41	46.23	64.11	72.9	106.16
Operating Profit	17.42	21.81	23.76	30.79	29.02
Other Income	4.27	2.94	4.48	5.68	4.83
Depreciation	3.73	3.6	3.21	3.35	2.87
Interest	2.48	1.77	0.71	0.44	0.43
Profit before tax and exceptio..	15.47	19.38	24.32	32.68	30.55
Exceptional Items	0	0	0	0	2.69
PBT	15.47	19.38	24.32	32.68	33.24
Provision for Taxation	5.36	6.94	9.25	12.11	12.1
Net Profit	10.12	12.44	15.07	20.58	21.14
NET Profit after MI	10.12	12.44	15.07	20.58	21.14
EPS	6.92	8.51	10.31	14.08	14.47
Operating Profit Margin (%)	12.66	15.39	14.26	16.49	12.96
Net Profit Margin (%)	7.35	8.78	9.05	11.02	9.44

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	46.50	50.60	50.60	50.60	50.60
FII	2.30	1.60	1.40	0.80	0.80
MF	9.20	6.80	6.80	6.80	6.80
Public	40.50	40.50	40.70	41.20	41.40
Others	0.10	0.00	0.00	0.20	0.20
Others	1.40	0.50	0.50	0.40	0.20